XML 34 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Summary of Assumptions that Used to Determine Grant-Date Fair Value of Stock Options Granted to Employees and Members of Board of Directors

The assumptions that the Company used to determine the grant-date fair value of stock options granted to employees and members of the board of directors were as follows, presented on a weighted-average basis:

 

 

Nine Months Ended September 30,

 

 

 

2022

 

 

2021

 

Expected option life (years)

 

 

5.96

 

 

 

6.07

 

Risk-free interest rate

 

 

1.80

%

 

 

0.76

%

Expected volatility

 

 

80.22

%

 

 

81.25

%

Expected dividend yield

 

 

%

 

 

%

 

Summary of Stock Option Activity

The following table summarizes the Company’s stock option activity for the nine months ended September 30, 2022:

 

 

Number of
Options

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term
(Years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding as of December 31, 2021

 

 

7,423,777

 

 

$

13.54

 

 

 

6.79

 

 

$

1,469

 

Granted

 

 

3,455,157

 

 

$

1.79

 

 

 

 

 

 

 

Exercised

 

 

 

 

$

 

 

 

 

 

 

 

Cancelled or forfeited

 

 

(2,795,571

)

 

$

11.99

 

 

 

 

 

 

 

Outstanding as of September 30, 2022

 

 

8,083,363

 

 

$

9.05

 

 

 

7.69

 

 

$

50

 

Exercisable as of September 30, 2022

 

 

3,266,645

 

 

$

12.69

 

 

 

5.87

 

 

$

50

 

Summary of Restricted Common Stock Units

The following table summarizes the Company’s restricted common stock units for the nine months ended September 30, 2022:

 

 

Number
of Shares

 

 

Weighted-
Average
Grant
Date Fair
Value

 

Issued and unvested as of December 31, 2021

 

 

599,850

 

 

$

9.64

 

Granted

 

 

850,168

 

 

$

1.62

 

Vested

 

 

(431

)

 

$

15.65

 

Forfeited, cancelled or expired

 

 

(579,051

)

 

$

6.56

 

Issued and unvested as of September 30, 2022

 

 

870,536

 

 

$

3.85

 

Schedule of Stock-based Compensation Expense

Stock-based compensation expense was allocated as follows:

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Research and development

$

448

 

 

$

1,965

 

 

$

2,169

 

 

$

5,989

 

General and administrative

 

2,208

 

 

 

3,204

 

 

 

7,098

 

 

 

8,505

 

Total stock-based compensation expense

$

2,656

 

 

$

5,169

 

 

$

9,267

 

 

$

14,494